Skip to main content
TipRanks
Go Ultimate75% OFF

Charmacy Pharmaceutical Co., Ltd. Class H (2289) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Charmacy Pharmaceutical Co., Ltd. Class H has a market cap or net worth of HKD 592.92M. The enterprise value is HKD 2.75B.

Market Cap
HKD 592.92M
Enterprise Value
HKD 2.75B

Share Statistics

Charmacy Pharmaceutical Co., Ltd. Class H has 108,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
108,000,000
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Charmacy Pharmaceutical Co., Ltd. Class H’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 1.80%.

Return on Equity (ROE)
0.08
Return on Assets (ROA)
0.01
Return on Invested Capital (ROIC)
1.80%
Return on Capital Employed (ROCE)
0.10
Revenue Per Employee
5.30M
Profits Per Employee
55.95K
Employee Count
827
Asset Turnover
1.11
Inventory Turnover
5.08

Valuation Ratios

The current PE Ratio of Charmacy Pharmaceutical Co., Ltd. Class H is 10.84. Charmacy Pharmaceutical Co., Ltd. Class H’s PEG ratio is -2.44.

PE Ratio
10.84
PS Ratio
0.11
PB Ratio
0.83
Price to FCF
1.61
Price to Operating Cash Flow
1.58
PEG Ratio
-2.44

Income Statement

In the last 12 months, Charmacy Pharmaceutical Co., Ltd. Class H had revenue of 4.38B and earned 46.27M in profits. Earnings per share was 0.43.

Revenue
4.38B
Gross Profit
336.01M
Operating Income
68.10M
Pretax Income
64.31M
Net Income
46.27M
EBITDA
166.97M
Earnings Per Share (EPS)
0.43

Cash Flow

In the last 12 months, operating cash flow was 317.99M and capital expenditures -6.05M, giving a free cash flow of 311.94M billion.

Operating Cash Flow
317.99M
Free Cash Flow
311.94M
Free Cash Flow per Share
2.89

Dividends & Yields

Charmacy Pharmaceutical Co., Ltd. Class H pays an annual dividend of HKD 0.49, resulting in a dividend yield of 6.26%

Dividend Per Share
HKD 0.49
Dividend Yield
6.26%
Payout Ratio
N/A
Free Cash Flow Yield
61.95%
Earnings Yield
9.35%

Stock Price Statistics

Beta
-0.25
52-Week Price Change
-22.13%
50-Day Moving Average
5.49
200-Day Moving Average
5.73
Relative Strength Index (RSI)
9.18
Average Volume (3m)
32.38K

Important Dates

Charmacy Pharmaceutical Co., Ltd. Class H upcoming earnings date is Mar 26, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 31, 2026
Next Earnings Date
Mar 26, 2027
Ex-Dividend Date
May 26, 2025

Financial Position

Charmacy Pharmaceutical Co., Ltd. Class H as a current ratio of 1.09, with Debt / Equity ratio of 338.89%

Current Ratio
1.09
Quick Ratio
0.84
Debt to Market Cap
2.92
Net Debt to EBITDA
8.00
Interest Coverage Ratio
1.11

Taxes

In the past 12 months, Charmacy Pharmaceutical Co., Ltd. Class H has paid 18.04M in taxes.

Income Tax
18.04M
Effective Tax Rate
0.28

Enterprise Valuation

Charmacy Pharmaceutical Co., Ltd. Class H EV to EBITDA ratio is 12.86, with an EV/FCF ratio of 6.62.

EV to Sales
0.44
EV to EBITDA
12.86
EV to Free Cash Flow
6.62
EV to Operating Cash Flow
6.49

Balance Sheet

Charmacy Pharmaceutical Co., Ltd. Class H has HKD 530.00M in cash and marketable securities with HKD 2.09B in debt, giving a net cash position of -HKD 1.56B billion.

Cash & Marketable Securities
HKD 530.00M
Total Debt
HKD 2.09B
Net Cash
-HKD 1.56B
Net Cash Per Share
-HKD 14.46
Tangible Book Value Per Share
HKD 4.94

Margins

Gross margin is 7.24%, with operating margin of 2.09%, and net profit margin of 1.01%.

Gross Margin
7.24%
Operating Margin
2.09%
Pretax Margin
1.42%
Net Profit Margin
1.01%
EBITDA Margin
3.43%
EBIT Margin
2.69%

Analyst Forecast

The average price target for Charmacy Pharmaceutical Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
14.25%
EPS Growth Forecast
0.83%

Scores

Smart Score
5
AI Score
47